期刊文献+

脊柱内固定术后耐甲氧西林金黄色葡萄球菌感染的研究进展 被引量:4

Research progress of methicillin-resistant Staphylococcus aureus infection after spinal internal fixation surgery
下载PDF
导出
摘要 脊柱内固定术常用于治疗椎管狭窄、脊柱侧弯以及椎体滑脱等各类脊柱疾病。随着脊柱外科手术技术的不断进步以及内固定材料的发展,脊柱内固定术的手术量逐年增加。目前尽管手术无菌条件有了很大进步,但脊柱术后感染仍是脊柱内固定术后影响患者治愈率和生存率的一个不可忽视的问题,尤其是脊柱内固定术后耐甲氧西林金黄色葡萄球菌(MRSA)感染,不仅增加了医疗费用及患者身心负担,而且可能导致内固定术的失败,甚至威胁患者生命。本文对脊柱内固定术后MRSA感染的治疗及预防措施等相关问题进行综述。 Spinal internal fixation surgery is often used to treat spinal diseases such as spinal stenosis,scoliosis and spondylolisthesis.With the continuous progress of spinal surgery technology and evolution of internal fixation materials,the amount of spinal internal fixation surgery is increasing year by year.Although the current aseptic condition of surgery has made great progress,post-operative spinal infection is still a problem that can not be ignored,which affects the cure rate and survival rate of patients after spinal internal fixation surgery,especially methicillin-resistant Staphylococcus aureus(MRSA)infection after spinal internal fixation surgery,which not only increases the medical cost as well as physical and mental burden of patients,but also may lead to the failure of internal fixation surgery and even threaten life.This paper reviews the treatment and prevention of MRSA infection after spinal internal fixation surgery.
作者 王旭 巩慧妍 李沐风 郑晟源 朱宇航 朱庆三 WANG Xu;GONG Hui-yan;LI Mu-feng;ZHENG Sheng-yuan;ZHU Yu-hang;ZHU Qing-san(Department of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun 130000, China;Department of Stomatology, The Second Hospital of Jilin University, Changchun 130000, China)
出处 《中国感染控制杂志》 CAS CSCD 北大核心 2022年第5期505-510,共6页 Chinese Journal of Infection Control
关键词 脊柱内固定术 耐甲氧西林金黄色葡萄球菌 手术部位感染 spinal internal fixation surgery methicillin-resistant Staphylococcus aureus surgical site infection
  • 相关文献

参考文献3

二级参考文献19

  • 1田耘,陈仲强,周方,刘忠军.脊柱术后伤口深部感染的处理[J].中华外科杂志,2005,43(4):229-231. 被引量:71
  • 2Arias CA. Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J].N Engl J Med. 2009. 360(5): 439-443.
  • 3Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Twentyfourth informational supplement. 2014. M100-S24 Vol 34 No. 1.
  • 4Hu F. Chen S. Xu X. et al. Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai. China[J]. J Med Microbiol , 2012. 61 (Pr 1): 132- 136.
  • 5Brink AJ. Feldman C. Grolman DC. et al. Appropriate use of the carbapenems[J]. S Afr Med J. 2004. 94 (10 Pt 2): 857-861.
  • 6Chen S. Hu F. Zhang X. et al. Independent emergence of colistin-resistant Enterobacteriaceae clinical isolates without colistin treatrnentj]]. J Clin Microbiol , 2011. 49( 11): 4022- 4023.
  • 7van Duin D. Kaye KS. Neuner EA. et al. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes[J]. Diagn Microbiol Infect Dis. 2013. 75(2): l1S-120.
  • 8Daikos GL. Tsaousi S. Tzouvelekis LS. et al. Carbapenemaseproducing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems [J]. Antimicrob Agents Chernother , 2014.58 (4): 2322-2328.
  • 9Tascini C. Tagliaferri E. Giani T. et al. Synergistic activity of colistin plus rifampin against colistin-resistant KPCproducing Klebsiella pneumoniae [J]. Antimicrob Agents Chernother , 2013. 57 (8): 3990-3993.
  • 10Pulcini C. Bush K. Craig WA. et al. Forgotten Antibiotics: an Inventory in Europe. the United States. Canada. and Australia[J]. Clin Infect Dis. 2012. 54(2): 268-274.

共引文献1182

同被引文献44

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部